Cargando…
Modification of mesenchymal stem cells for cartilage-targeted therapy
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by the destruction of the articular cartilage, sclerosis of the subchondral bone, and joint dysfunction. Its pathogenesis is attributed to direct damage and mechanical destruction of joint tissues. Mesenchymal stem cells (MSCs...
Autores principales: | Huang, Jianghong, Liu, Qisong, Xia, Jiang, Chen, Xi, Xiong, Jianyi, Yang, Lei, Liang, Yujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644530/ https://www.ncbi.nlm.nih.gov/pubmed/36348497 http://dx.doi.org/10.1186/s12967-022-03726-8 |
Ejemplares similares
-
Advanced Nanocomposite Hydrogels for Cartilage Tissue Engineering
por: Huang, Jianghong, et al.
Publicado: (2022) -
Repair of articular cartilage defects with intra-articular injection of autologous rabbit synovial fluid-derived mesenchymal stem cells
por: Jia, Zhaofeng, et al.
Publicado: (2018) -
Stem Cell-Derived Nanovesicles: A Novel Cell-Free Therapy for Wound Healing
por: Huang, Jianghong, et al.
Publicado: (2021) -
3D Bioprinting of Hydrogels for Cartilage Tissue Engineering
por: Huang, Jianghong, et al.
Publicado: (2021) -
Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification
por: Liu, Qisong, et al.
Publicado: (2023)